Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06512064 · ClinicalTrials.gov registry record · NA

Acoustic Waveform Respiratory Evaluation

A NA study of Asthma and Cystic Fibrosis, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
2
Study locations

NCT06512064 is a NA study of Asthma and Cystic Fibrosis that is actively recruiting participants, run by Indiana University. The registered enrollment target is 800 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (49% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06512064, a NA study of Asthma and Cystic Fibrosis, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
2
Study locations

Study Summary

The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.

Interventions

  • DIAGNOSTIC_TEST AWARE

Study Locations (2)

Indiana

  • Indiana University - Indianapolis

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2024-07-23
Est. Completion 2029-04
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06512064

The ClinicalTrials.gov registry entry for NCT06512064 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (49% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which AWARE is the first listed.

NCT06512064 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06512064 about?

NCT06512064 is a clinical study titled "Acoustic Waveform Respiratory Evaluation". The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.

What is the current status of trial NCT06512064?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2024-07-23. Estimated completion is 2029-04.

What conditions does trial NCT06512064 study?

This clinical trial studies the following conditions: Asthma, Cystic Fibrosis, COPD, Bronchiectasis, Healthy Control.

What interventions are being tested in trial NCT06512064?

The interventions under investigation include: AWARE (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06512064?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06512064 being conducted?

This trial has 2 study locations across Indiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.